开发和验证一个基于临床参数的手术前脑图,以预测透露性肝脑病变,在经内肝内移植系统分离术后1年内
Zhimeng Jiang1,2, Jianguo Chu2, Zheyi Han2
1Graduate School of Hebei North University, Zhangjiakou, Hebei Province, China.
Frontiers in medicine
|November 5, 2025
概括
使用手术前临床因素的新预测模型准确地评估了肝硬化患者经过横内肝移植系统分流 (TIPS) 后明显肝脑病变 (OHE) 的风险. 这种工具有助于临床决策,以改善患者的治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 干预性放射学 干预性放射学
- 临床预测建模模型
背景情况:
- 横性肝内移植系统分流 (TIPS) 对于在不补偿性肝硬化中管理门门高血压并发症至关重要.
- 开放性肝脑病变 (OHE) 是TIPS后的频繁且严重的并发症,影响患者的预后和生活质量.
- 需要有效的预测模型来识别TIPS后OHE高风险患者.
研究的目的:
- 开发和验证OHE的实用,可访问和高性能预测模型.
- 该模型基于易于获得的TIPS患者手术前临床参数.
主要方法:
- 追溯分析440名患有不补偿性肝硬化症的患者,他们接受了他们的第一个TIPS.
- 患者被分为训练 (n=310) 和验证 (n=130) 队列.
- 最小绝对缩小和选择运算符 (LASSO) 回归和多变量逻辑回归被用来构建预测模型和名ogram.
主要成果:
- 确定了五个关键预测因素:预后营养指数 (PNI),年龄,以前的肝脑病史,血清氨和肌素.
- 该模型表现出高预测准确度,培训队列的AUC为0.8835,验证队列的AUC为0.858,表现优于MELD和CTP得分.
- 模型性能通过校准曲线,决策曲线分析 (DCA) 和临床影响曲线 (CIC) 进一步验证,显示出强大的准确性和临床实用性.
结论:
- 开发的预测模型准确地评估了肝硬化患者在TIPS后的一年内OHE的风险.
- 该模型是临床决策的有价值和实用的工具,有可能改善患者管理和结果.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
Hepatic Portal System
5.2K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
209
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
209


